Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Felipe José Silva Melo Cruz
Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer
Einstein (São Paulo, Brazil)
Medicine
Related publications
Circulating Lymphocyte Count During Neoadjuvant Chemoradiation Therapy for Esophageal Cancer as a Predictive Biomarker of Pathologic Complete Response
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer
Tumor Biology
Medicine
Cancer Research
Relevance of Pathological Complete Response After Neoadjuvant Therapy for Breast Cancer
Breast Cancer: Basic and Clinical Research
Cancer Research
Oncology
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Pathologic Evaluation of Breast Cancer After Neoadjuvant Therapy
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
The Nuclear Transcription Factor B/BCL-2 Pathway Correlates With Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Genome-Wide DNA Methylation Signatures to Predict Pathologic Complete Response From Combined Neoadjuvant Chemotherapy With Bevacizumab in Breast Cancer
PLoS ONE
Multidisciplinary
Predicting Successful Conservative Surgery After Neoadjuvant Chemotherapy in Hormone Receptor-Positive, HER2-Negative Breast Cancer
Journal of Breast Disease
Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer
JAMA Oncology
Cancer Research
Oncology
